Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. 28 Δεκ 2018 · Infectious acute respiratory failure and sepsis remain the leading causes of medical-oncologic ICU admissions; however, we are seeing a surge in elderly patients presenting with disease- or treatment-associated critical illness and unique toxicities associated with newer therapies.

  2. This Viewpoint gives an overview of the diagnosis and management of pulmonary toxicity arising from cancer immunotherapy, including widely used treatments, such as immune checkpoint inhibitors, and emerging therapies, such as chimeric antigen receptor T cells.

  3. 7 Μαρ 2024 · Patients with cancer who have development of acute respiratory failure (ARF) have significant morbidity, substantial health care utilization, and reduced survival. 1, 2 As a result of advances in cancer therapies, many patients with cancer survive longer, with growing numbers being admitted to the hospital and/or the intensive care unit (ICU ...

  4. Nosocomial infections or healthcare-acquired infections are a common cause of increased morbidity and mortality among hospitalized patients. Cancer patients are at an increased risk for these infections due to their immunosuppressed states.

  5. 15 Ιαν 2024 · Patients with cancer who develop COVID-19-related respiratory failure exhibit distinct clinical characteristics and have a higher likelihood of receiving specific COVID-19 treatments, such as remdesivir and corticosteroids, than those without cancer do.

  6. 28 Ιαν 2019 · Pneumonia is the most common cause of respiratory failure, yet there are many causes of respiratory insufficiency unique to the cancer patient. These causes are often a result of immunosuppression, chemotherapy, radiation treatment, or hematopoietic stem cell transplant (HCT).

  7. In cancer patients with acute respiratory failure (ARF), early adequate therapy is associated with better outcomes. We investigated the performance of the DIRECT approach, which uses criteria available at the bedside at admission to the intensive care unit (ICU), to identify causes of ARF in cancer patients.